TQB3617, a bromodomain and extra-terminal inhibitor, in patients with relapsed or refractory lymphoma: A multicenter, phase 1 trial

作者：Yuchen Zhang, Qingsong Yin, Baitian Zhao, Fang Liu, Li Su, Jun Cai, Xiaojie Fang, Bing Bai, Man Nie, Qihua Zou, Dawei Ding, Xin Wang, Jiajia Zhu, Yu Ding, Xunqiang Wang, Xiquan Zhang, Liang Wang, Yi Xia, Qingqing Cai · 发表于：Med · 年份：2025 · DOI：10.1016/j.medj.2025.100893 · 被引用次数：1 · 研究领域：Protein Degradation and Inhibitors、Histone Deacetylase Inhibitors Research、Multiple Myeloma Research and Treatments